A beverage company that has been riding the recent marijuana stock surge is using some of that equity to get bigger.

If one entrepreneur has his way, Manitoba will have as many places to buy cannabis as there are stores to purchase booze.

John Arbuthnot, co-founder of the cannabis producer and retailer Delta 9, said he thinks the province can accommodate more than 100 retail cannabis stores — a projection that may be possible if the retail market for cannabis opens up as promised. 

"You'll see the full scope," Arbuthnot said. "You'll see the bigger companies like Delta 9 trying to open dozens of stores as we originally announced was our intention, and you'll see now the opportunity for smaller one-off locations. Call it the mom and pop model."

As we continue to work through the cannabis stock correction, we continue to make our list of stocks that could work on the next leg, and OrganiGram Holdings Inc (OTCMKTS:OGRMF)continues to make a strong argument that it belongs on that list. Shares have been holding key 200-day MA support and the company continues to announce further expansion for its distribution footprint. As a case in point, the company just announced it has completed the registration process with Saskatchewan Liquor and Gaming Authority (SLGA), making it an official supplier of cannabis for the province. “We are pleased to have been selected as an official supplier of cannabis in Saskatchewan,” says Tim Emberg, Senior Vice President of Sales and Commercial Operations, Organigram.

A Toronto cannabis grower, with an operation near Kirkland Lake, has struck a supply and financing agreement with Canadian weed giant, Canopy Growth Corporation.

48North Cannabis Corp. announced Dec. 3 that it has entered into two agreements to supply the Smith Falls-headquartered producer with dried cannabis grown at its DelShen Therapeutics facility, just outside of Kirkland Lake.

Aurora Cannabis (NYSE:ACB,TSX:ACB) started shipping its cannabis softgel capsules for the Canadian medical and adult-use marijuana markets.

As quoted in the press release:

Aurora expects to commence exports to international markets in early 2019.

Smoking recreational cannabis is now legal in Canada for adults over 19 years old. According to Statistics Canada, 27 percent of people aged 15 to 24 and 13 per cent of people over 25 years old, use cannabis. That amounts to 4.6 million Canadians who currently consume products of the cannabis plant, which include marijuana and hashish.

Vancouver's reputation as the weed capital of the country is taking a hit after Statistics Canada released a new flush of data gleaned from studying sewage.

The report found that among five major Canadian cities, Vancouverites consume the least amount of pot per capita, based on the level of cannabis metabolites in samples of wastewater.

Halifax was found to have the highest rate of cannabis consumption per capita, at 1,310 micrograms per person per week, followed by Montreal at 976 micrograms, Toronto at 451 micrograms and Edmonton at 416 micrograms.

Vancouver registered just 288 microgram per person per week.

Here's a quick trivia question for you: What are the three largest U.S.-based marijuana stocks by market cap? If your answers included MariMed (NASDAQOTH:MRMD) and MedMen(NASDAQOTH:MMNFF), pat yourself on the back. (The third correct answer -- and the biggest of them all -- is Scotts Miracle-Gro.)

Constant back pain caused by a fall left Ash Basu in agony, so when his doctor suggested he see a cannabis specialist, he was intrigued.

The 64-year-old had no experience with marijuana, recreationally or otherwise, but had heard reports of the herb's pain-relieving potential and was eager to avoid opioids.

He was referred to a cannabis clinic and peppered the doctor with questions. He wasn't happy with what he heard.

"They didn't seem to have too much information," complains Basu, who was among several dozen seniors at a recent information session on medical marijuana in Toronto.

Just to be clear, the retail price of marijuana in Canada remains stable for now.

Now underway in full force in Canada, the legalization experiment has drawn attention from around the world. Canada is the first G7 country — and only the second country in the world — to legalize cannabis at the federal level. Absent accurate data to capture what consumers actually paid for their weed pre-legalization (it was illegal, after all), the government has made pricing and taxing decisions largely on the basis of what other regions of the U.S. and other Western nations have done in terms of medical and recreational marijuana pricing given the length of time many of these places have had to gather data.